[Allergic vasculitis caused by Vigabatrin].

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Der Nervenarzt

• Publication date

  1994-02-01

• Fields of study

  Medicine

• Identifiers
  PMID 8164764
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vigabatrin and psychosis.

  1991cited by this paper
• Anterior ischaemic optic neuropathy Differentiation of arteritic from non-arteritic type and its management

  1990cited by this paper
• Neuropathology of a human hippocampus following long-term treatment with vigabatrin: lack of microvacuoles.

  1990cited by this paper
• Micro-vacuolation in rat brains after long term administration of GABA-transaminase inhibitors. Comparison of effects of ethanolamine-O-sulphate and vigabatrin.

  1987cited by this paper

• The Pharmacology and Toxicology of Third-Generation Anticonvulsant Drugs

  2017cites this paper
• Autoimmunity in visual loss

  2016influential citation
• Study of visual field defects in patients with epilepsy receiving Vigabatrin

  2009cites this paper
• Cutaneous and Systemic Manifestations of Drug-Induced Vasculitis

  2002cites this paper
• Effects of antiepileptic drugs on visual function, with special reference to Vigabatrin.

  2002cites this paper
• Visual Field Defects with Vigabatrin

  2001cites this paper
• Adverse Reactions to New Anticonvulsant Drugs

  2000cites this paper
• Recovery of visual field constriction following discontinuation of vigabatrin.

  2000cites this paper
• Visual field defects associated with vigabatrin therapy

  1999cites this paper
• Vigabatrin-induced optic neuropathy

  1997cites this paper
• Annotation: tuberous sclerosis.

  1997cites this paper
• Severe persistent visual field constriction associated with vigabatrin

  1997cites this paper
• Vigabatrin

  1996cites this paper
• [Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic].

  1995cites this paper